CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-09 | RAKIN KEVIN Director | Option exercise | +6,666 | $4.80 | $32K | 25,741 |
| 2021-08-09 | RAKIN KEVIN Director | Shares withheld for taxes | −1,517 | $21.09 | $32K | 24,224 |
| 2021-08-09 | RAKIN KEVIN Director | Option exercise | +10,000 | $4.17 | $42K | 34,224 |
| 2021-08-09 | RAKIN KEVIN Director | Shares withheld for taxes | −1,977 | $21.09 | $42K | 32,247 |
| 2021-08-09 | RAKIN KEVIN Director | Option exercise | +56,773 | $7.77 | $441K | 89,020 |
| 2021-08-09 | RAKIN KEVIN Director | Shares withheld for taxes | −20,916 | $21.09 | $441K | 68,104 |
| 2021-08-09 | RAKIN KEVIN Director | Option exercise · Stock Option (right to buy) | −5,697 | 0 | ||
| 2021-08-09 | RAKIN KEVIN Director | Option exercise · Stock Option (right to buy) | −6,666 | 0 | ||
| 2021-08-09 | RAKIN KEVIN Director | Option exercise · Stock Option (right to buy) | −10,000 | 0 | ||
| 2021-08-09 | RAKIN KEVIN Director | Option exercise · Stock Option (right to buy) | −56,773 | 0 | ||
| 2021-08-09 | KIDRON NADAV President and CEO | Sale | −220,000 | $20.11 | $4.4M | 648,573 |
| 2021-08-04 | Rabinowitz Michael Chief Commercial Officer | Grant or award | +100,000 | 100,000 | ||
| 2021-08-04 | Rabinowitz Michael Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-02-26 | Sank Leonard Director | Other disposition | −375,000 | $3.68 | $1.4M | 0 |
| 2021-02-26 | Sank Leonard Director | Other disposition | −78,125 | $3.68 | $288K | 0 |
| 2021-02-17 | RAKIN KEVIN Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-02-03 | Kidron Miriam Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-02-03 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2021-02-03 | Hexter Joshua COO, Business Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-02-03 | Gabay Avraham CFO, Treasurer and Secretary | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 |
Page 12 of 18 · 349 trades